Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$1B-2.7%$995.83M+1.2%$994.23M-0.8%$1B-0.5%$1.03B+0.6%
$228.9M+19.5%$159.42M-10.3%$196.14M+0.2%$177.59M-10.9%$191.55M+12.8%
$119.89M+19.7%$119.9M+60.6%$133.8M+14.0%$100.13M-34.0%
11.9%+2.2pp12%+4.5pp13.3%+1.7pp9.7%-5.1pp
$30.34M+1.2%$26.74M-4.1%$23.78M-15.8%$25.4M-16.1%$29.97M-8.6%
-$37.41M-24,392%-$124.13M-917%-$22.62M-973%$154K+107%
$53.93M+188%-$15.14M-250%$31.64M+51.1%$18.73M-26.3%
-$1.48M-103%-$14.84M-158%-$276.56M$54.42M-21.9%$52.33M-44.4%
-0.1%-5.2pp-1.5%-4.1pp-27.8%5.4%-1.5pp5.1%-4.1pp
-$0.03-103%-$0.30-160%-$5.56$1.10-17.3%$1.06-39.1%
$187.18M-14.8%$187.05M-4.1%$77.18M-49.8%$218.96M+6.5%$219.64M-7.6%
18.6%-2.6pp18.8%-1.0pp7.8%-7.6pp21.8%+1.4pp21.3%-1.9pp
$119.89M+19.7%$119.9M+60.6%-$1.1M-102%$133.8M+14.0%$100.13M-34.0%

FAQ

What is Charles River Laboratories's revenue?
Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, down 0.7% year over year.
Is Charles River Laboratories profitable?
Charles River Laboratories is not currently profitable: it reported a net loss of $238.5M over the trailing twelve months, a -6.0% net margin.
What are Charles River Laboratories's profit margins?
Gross margin is 84.7% and operating margin is 13.0%, with a -6.0% net margin.
What is Charles River Laboratories's earnings per share?
Charles River Laboratories's diluted EPS over the trailing twelve months is $-4.79.
Where does Charles River Laboratories's income statement data come from?
Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.